JPMorgan Chase & Co’s SQZ Biotechnologies Company SQZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,075
| Closed | -$5K | – | 6129 |
|
2022
Q3 | $5K | Sell |
2,075
-128,172
| -98% | -$309K | ﹤0.01% | 5209 |
|
2022
Q2 | $414K | Buy |
130,247
+13,016
| +11% | +$41.4K | ﹤0.01% | 3980 |
|
2022
Q1 | $564K | Sell |
117,231
-8,882
| -7% | -$42.7K | ﹤0.01% | 3936 |
|
2021
Q4 | $1.13M | Sell |
126,113
-110,896
| -47% | -$990K | ﹤0.01% | 3601 |
|
2021
Q3 | $3.42M | Buy |
237,009
+54,980
| +30% | +$793K | ﹤0.01% | 2825 |
|
2021
Q2 | $2.63M | Buy |
182,029
+166,879
| +1,102% | +$2.41M | ﹤0.01% | 3061 |
|
2021
Q1 | $207K | Buy |
15,150
+2,992
| +25% | +$40.9K | ﹤0.01% | 4439 |
|
2020
Q4 | $352K | Buy |
+12,158
| New | +$352K | ﹤0.01% | 3931 |
|